返回
WuXi XDC Cayman Inc.（02268.HK）價格
02268.HK 股價走勢圖
WUXI XDC (02268.HK)
WuXi XDC Cayman Inc.
HK$69
-2.61%
$-1.84
盤中： Jan 19, 15:24:19 HKT
暫無資料Earnings FAQ
02268.HK 最近的每股盈餘與預期相比如何？
WuXi XDC Cayman Inc. 02268.HK 上一季度的收入表現如何？
WuXi XDC Cayman Inc. 的收入預期是多少？
WuXi XDC Cayman Inc. 的盈利品質評分是多少？
WuXi XDC Cayman Inc. 何時發布財報？
WuXi XDC Cayman Inc. 的預期收益是多少？
WuXi XDC Cayman Inc. 是否超出收益預期？
關鍵數據
前收市價
$70.85
開盤價
$70.85
當日範圍
$67.5 - $71.5
52週區間
$24.7 - $85.5
交易量
4.5M
平均成交量
5.4M
每股盈餘 (TTM)
1.13
股息收益率
--
市值
$86.6B
什麼是 WUXI XDC？
WuXi XDC Cayman, Inc. is an investment holding company, which engages in research, discovery, development, and manufacturing of the drug substances and drug products of antibody drug conjugates and other bio conjugates. The company is headquartered in Wuxi, Jiangsu and currently employs 2,270 full-time employees. The company went IPO on 2023-11-17. The firm's services include the discovery, process development and Good Manufacturing Practice (GMP) manufacturing for bioconjugates, monoclonal antibody intermediates and payload-linkers associated with bioconjugates. The firm provides CRDMO services to customers through contracts under fee-for-service (FFS) basis and contracts under full-time equivalent (FTE) basis. The firm principally conducts its businesses in domestic and overseas markets, including North America, Europe and the rest of the world.